semaglutide baylor scott and white University Medical Center Area of Greatest Need Meet the Doctor Leading Baylor

Why GLP-1 Agonists May Not Be Safe for People with Type 1 Diabetes Eric Han Feb 23 4 min read GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), liraglutide (Victoza), and tirzepatide (Mounjaro, Zepbound) have dramatically improved treatment options for Type 2 diabetes and obesity

Rather than serving as a first-line treatment, it is typically considered an adjunctive therapy that may complement more established approaches, such as physical therapy, exercise modification, and other evidence-based interventions

In contrast, younger patients may experience milder volume depletion and more resilient skin, requiring lighter or more targeted interventions

The nationwide poll was conducted January 9-13, 2025 using the AmeriSpeak Panel, the probability-based panel of NORC at the University of Chicago

Medical service experts or specialists in sexual health provide personalized supervision based on a person's health history, general health state, and specific requirements